SCHEMBL9068614

SCHEMBL9068614

CC1CC(C(=O)O)C(C(=O)O)CC1C

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GABRR1 P24046 5/20 0.48
GABRR2 P28476 1/20 0.40
GRM2 Q14416 2/20 0.39
CHRNB2 P17787 4/20 0.38
CHRNA3 P32297 4/20 0.38
CHRNA4 P43681 4/20 0.38
CHRNB3 Q05901 4/20 0.38
CHRNA6 Q15825 4/20 0.38
PPP5C P53041 1/20 0.38
LMNA P02545 2/20 0.37
CYP2C9 P11712 1/20 0.37
CYP2C19 P33261 1/20 0.37
GRM8 O00222 1/20 0.37
GRM6 O15303 1/20 0.37
APEX1 P27695 1/20 0.37
GRM5 P41594 1/20 0.37
PMP22 Q01453 1/20 0.37
GRM1 Q13255 1/20 0.37
GRM3 Q14832 1/20 0.37
GRM4 Q14833 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8115501 0.90
SCHEMBL1375335 0.90
SCHEMBL30287516 0.90
SCHEMBL440352 0.90
SCHEMBL5521450 0.90
SCHEMBL438545 0.90
SCHEMBL4920447 0.90
SCHEMBL265423 0.90
SCHEMBL1688785 0.90
SCHEMBL13867209 0.89 GABRR1 (0.40) GABRR1GABRR2GRM2CHRNB2CHRNA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112714759-B Metal salt, crystallization nucleating agent composition, polyolefin resin composition, and polyolefin resin molded body 新日本理化株式会社 2023-12-12 CN disclosed
US-20230295406-A1 POLYPROPYLENE-BASED RESIN COMPOSITION SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2023-09-21 US disclosed
US-20230250265-A1 POLYPROPYLENE RESIN COMPOSITION SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2023-08-10 US disclosed
US-20230250265-A1 POLYPROPYLENE RESIN COMPOSITION SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2023-08-10 US disclosed
US-20220213016-A1 Methods for Making Functionalized Fluorinated Monomers, Fluorinated Monomers, and Compositions for Making the Same ETNA-TEC, LTD. 2022-07-07 US disclosed
CN-112714759-A Alicyclic dicarboxylic acid metal salt having excellent dispersibility in polyolefin resin, method for producing alicyclic dicarboxylic acid metal salt, crystal nucleating agent for polyolefin resin comprising alicyclic dicarboxylic acid metal salt, crystal nucleating agent composition comprising crystal nucleating agent, polyolefin resin composition, and polyolefin resin molded product 新日本理化株式会社 2021-04-27 CN disclosed
WO-2020054492-A1 METAL SALT OF ALICYCLIC DICARBOXYLIC ACID HAVING EXCELLENT DISPERSIBILITY IN POLYOLEFIN RESIN, PRODUCTION METHOD FOR SAID METAL SALT OF ALICYCLIC DICARBOXYLIC ACID, CRYSTAL NUCLEATOR FOR POLYOLEFIN RESIN CONTAINING SAID METAL SALT OF ALICYCLIC DICARBOXYLIC ACID, CRYSTAL NUCLEATOR COMPOSITION CONTAINING SAID CRYSTAL NUCLEATOR, POLYOLEFIN RESIN COMPOSITION, AND POLYOLEFIN RESIN MOLDED ARTICLE 新日本理化株式会社 2020-03-19 WO disclosed
US-9784897-B2 Optical film, polarizing plate and liquid crystal display device FUJIFILM CORPORATION (JP) 2017-10-10 US disclosed
US-9505957-B2 Polyolefin adhesive compositions comprising nucleating agents for improved set time EXXONMOBIL CHEMICAL PATENTS INC. (US) 2016-11-29 US disclosed
US-9505957-B2 Polyolefin adhesive compositions comprising nucleating agents for improved set time EXXONMOBIL CHEMICAL PATENTS INC. (US) 2016-11-29 US disclosed
US-7671947-B2 Optical film, optical compensation film, polarizing plate, liquid crystal display unit and self luminous display unit FUJIFILM CORPORATION (JP) 2010-03-02 US disclosed
US-20090290100-A1 Cellulose Acylate Film, Method of Producing the Same, Cellulose Derivative Film, Optically Compensatory Film Using the Same, Optically-Compensatory Film Incorporating Polarizing Plate, Polarizing Plate and Liquid Crystal Display Device FUJIFILM CORPORATION (JP) 2009-11-26 US disclosed
US-20090122243-A1 Liquid Crystal Display Device, Optical Compensatory Sheet, and Polarizer and Liquid Crystal Display Device Employing the Same FUJIFILM CORPORATION (JP) 2009-05-14 US disclosed
US-7505100-B2 Liquid crystal display device FUJIFILM CORPORATION (JP) 2009-03-17 US disclosed
US-20090021671-A1 Cellulose Acylate Film, Method for Producing Cellulose Acylate Film, Polarizing Plate and Liquid Crystal Display Device FUJIFILM CORPORATION (JP) 2009-01-22 US disclosed
US-20080309860-A1 Optical Film, Optical Compensation Film, Polarizing Plate, Liquid Crystal Display Unit and Self Luminous Display Unit FUJIFILM CORPORATION (JP) 2008-12-18 US disclosed
US-20080254237-A1 Polymer Film, and Optically-Compensatory Film, Polarizer and Liquid-Crystal Display Device Comprising the Same FUJIFILM CORPORATION (JP) 2008-10-16 US disclosed
US-20080062357-A1 CYCLIC OLEFIN RESIN FILM, POLARIZING PLATE AND LIQUID CRYSTAL DISPLAY DEVICE FUJIFILM CORPORATION (JP) 2008-03-13 US disclosed
US-20080043177-A1 Liquid Crystal Display Device FUJIFILM CORPORATION (JP) 2008-02-21 US disclosed
US-4010289-A METHOD OF MANUFACTURING SYNTHETIC RESIN FILM HAVING HIGH WRITABILITY AND PRINTABILITY SHOWA DENKO KABUSHIKI KAISHA (JA) 1977-03-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220213016-A1 Methods for Making Functionalized Fluorinated Monomers, Fluorinated Monomers, and Compositions for Making the Same ALKBH3, FTO, ALK GABRR1 1274/4885GABRR2 1235/4885GRM2 3606/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.